Bibliografia
Bevilacqua A, Bizzarri M (2016) Physiological role and clinical utility of inositols in polycystic ovary syndrome. Best Practice & Research Clinical Obstetrics & Gynaecology
Livermore TM, Azevedo C, Kolozsvari B, Wilson MS, Saiardi A (2016) Phosphate, inositol and polyphosphates. Biochem Soc Trans 44(1):253–259
Manna P, Jain SK (2015) Phosphatidylinositol-3,4,5-triphosphate and cellular signaling: implications for obesity and diabetes. Cell Physiol Biochem 35(4):1253–1275
Lauretta R, Lanzolla G, Vici P, Mariani L, Moretti C, Appetecchia M (2016) Insulin-sensitizers, polycystic ovary syndrome and gynaecological cancer risk. Int J Endocrinol 2016:8671762
Monastra G, Unfer V, Harrath AH, Bizzarri M (2017) Combining treatment with myo-inositol and D-chiro-inositol (40:1) is effective in restoring ovary function and metabolic balance in PCOS patients. Gynecol Endocrinol 33(1):1–9
Unfer V, Carlomagno G, Dante G, Facchinetti F (2012) Effects of myo-inositol in women with PCOS: a systematic review of randomized controlled trials. Gynecol Endocrinol 28(7):509–515
Chattopadhayay R, Ganesh A, Samanta J, Jana SK, Chakravarty BN, Chaudhury K (2010) Effect of follicular fluid oxidative stress on meiotic spindle formation in infertile women with polycystic ovarian syndrome. Gynecol Obstet Investig 69:197–202
Rago R, Marcucci I, Leto G, Caponecchia L, Salacone P, Bonanni P, Fiori C, Sorrenti G, Sebastianelli A (2015) Effect of myo-inositol and alpha-lipoic acid on oocyte quality in polycystic ovary syndrome non-obese women undergoing in vitro fertilization: a pilot study. J Biol Regul Homeost Agents 29(4):913–923
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflitto di interesse
Gli autori dichiarano di non avere conflitti di interesse.
Consenso informato
L’articolo è di revisione della letteratura e linea guida terapeutica; non è uno studio che ha richiesto sperimentazione umana.
Studi su animali
L’articolo è di revisione della letteratura e linea guida terapeutica; non è uno studio che ha richiesto sperimentazione su modelli animale.
Rights and permissions
About this article
Cite this article
Moretti, C., Lanzolla, G. Uso dell’inositolo nella sindrome dell’ovaio policistico. L'Endocrinologo 19 (Suppl 1), 17–19 (2018). https://doi.org/10.1007/s40619-018-0412-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40619-018-0412-9